Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2001 May;84(5):383–386. doi: 10.1136/adc.84.5.383

Meningococcal group C conjugate vaccines

J MAcLENNAN 1
PMCID: PMC1718752  PMID: 11316676

Full Text

The Full Text of this article is available as a PDF (136.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. L., Bowers T., Mink C. M., Kennedy D. J., Belshe R. B., Harakeh H., Pais L., Holder P., Carlone G. M. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect Immun. 1994 Aug;62(8):3391–3395. doi: 10.1128/iai.62.8.3391-3395.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Artenstein M. S., Brandt B. L. Immunologic hyporesponsiveness in man to group C meningococcal polysaccharide. J Immunol. 1975 Jul;115(1):5–7. [PubMed] [Google Scholar]
  3. Artenstein M. S., Gold R., Zimmerly J. G., Wyle F. A., Schneider H., Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970 Feb 19;282(8):417–420. doi: 10.1056/NEJM197002192820803. [DOI] [PubMed] [Google Scholar]
  4. Borrow R., Fox A. J., Cartwright K., Begg N. T., Jones D. M. Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine. Epidemiol Infect. 1999 Oct;123(2):201–208. doi: 10.1017/s0950268899002915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Borrow R., Richmond P., Kaczmarski E. B., Iverson A., Martin S. L., Findlow J., Acuna M., Longworth E., O'Connor R., Paul J. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine. FEMS Immunol Med Microbiol. 2000 May;28(1):79–85. doi: 10.1111/j.1574-695X.2000.tb01460.x. [DOI] [PubMed] [Google Scholar]
  6. Choo S., Zuckerman J., Goilav C., Hatzmann E., Everard J., Finn A. Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial. Vaccine. 2000 Jun 1;18(24):2686–2692. doi: 10.1016/s0264-410x(00)00050-5. [DOI] [PubMed] [Google Scholar]
  7. Dagan R., Eskola J., Leclerc C., Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun. 1998 May;66(5):2093–2098. doi: 10.1128/iai.66.5.2093-2098.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De Wals P., Dionne M., Douville-Fradet M., Boulianne N., Drapeau J., De Serres G. Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada. Bull World Health Organ. 1996;74(4):407–411. [PMC free article] [PubMed] [Google Scholar]
  9. Fairley C. K., Begg N., Borrow R., Fox A. J., Jones D. M., Cartwright K. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J Infect Dis. 1996 Dec;174(6):1360–1363. doi: 10.1093/infdis/174.6.1360. [DOI] [PubMed] [Google Scholar]
  10. Fogarty J. Trends in serogroup C meningococcal disease in the Republic of Ireland. Euro Surveill. 1997 Oct;2(10):75–76. doi: 10.2807/esm.02.10.00148-en. [DOI] [PubMed] [Google Scholar]
  11. Gheesling L. L., Carlone G. M., Pais L. B., Holder P. F., Maslanka S. E., Plikaytis B. D., Achtman M., Densen P., Frasch C. E., Käyhty H. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol. 1994 Jun;32(6):1475–1482. doi: 10.1128/jcm.32.6.1475-1482.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gilmore A., Jones G., Barker M., Soltanpoor N., Stuart J. M. Meningococcal disease at the University of Southampton: outbreak investigation. Epidemiol Infect. 1999 Oct;123(2):185–192. doi: 10.1017/s0950268899002794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gold R., Artenstein M. S. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ. 1971;45(3):279–282. [PMC free article] [PubMed] [Google Scholar]
  14. Gold R., Goldschneider I., Lepow M. L., Draper T. F., Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis. 1978 Feb;137(2):112–121. doi: 10.1093/infdis/137.2.112. [DOI] [PubMed] [Google Scholar]
  15. Gold R., Lepow M. L., Goldschneider I., Gotschlich E. C. Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis. J Infect Dis. 1977 Aug;136 (Suppl):S31–S35. doi: 10.1093/infdis/136.supplement.s31. [DOI] [PubMed] [Google Scholar]
  16. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med. 1969 Jun 1;129(6):1327–1348. doi: 10.1084/jem.129.6.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Granoff D. M., Gupta R. K., Belshe R. B., Anderson E. L. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis. 1998 Sep;178(3):870–874. doi: 10.1086/515346. [DOI] [PubMed] [Google Scholar]
  18. Granoff D. M., Maslanka S. E., Carlone G. M., Plikaytis B. D., Santos G. F., Mokatrin A., Raff H. V. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol. 1998 Jul;5(4):479–485. doi: 10.1128/cdli.5.4.479-485.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Guirguis N., Schneerson R., Bax A., Egan W., Robbins J. B., Shiloach J., Orskov I., Orskov F., el Kholy A. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies. J Exp Med. 1985 Dec 1;162(6):1837–1851. doi: 10.1084/jem.162.6.1837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Heath P. T. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S117–S122. doi: 10.1097/00006454-199809001-00005. [DOI] [PubMed] [Google Scholar]
  21. Jackson L. A., Schuchat A., Reeves M. W., Wenger J. D. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA. 1995 Feb 1;273(5):383–389. [PubMed] [Google Scholar]
  22. King W. J., MacDonald N. E., Wells G., Huang J., Allen U., Chan F., Ferris W., Diaz-Mitoma F., Ashton F. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children. J Pediatr. 1996 Feb;128(2):196–202. doi: 10.1016/s0022-3476(96)70389-x. [DOI] [PubMed] [Google Scholar]
  23. Kwara A., Adegbola R. A., Corrah P. T., Weber M., Achtman M., Morelli G., Caugant D. A., Greenwood B. M. Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health. 1998 Sep;3(9):742–746. doi: 10.1046/j.1365-3156.1998.00300.x. [DOI] [PubMed] [Google Scholar]
  24. Leach A., Twumasi P. A., Kumah S., Banya W. S., Jaffar S., Forrest B. D., Granoff D. M., LiButti D. E., Carlone G. M., Pais L. B. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis. 1997 Jan;175(1):200–204. doi: 10.1093/infdis/175.1.200. [DOI] [PubMed] [Google Scholar]
  25. Lieberman J. M., Chiu S. S., Wong V. K., Partidge S., Chang S. J., Chiu C. Y., Gheesling L. L., Carlone G. M., Ward J. I. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial. JAMA. 1996 May 15;275(19):1499–1503. [PubMed] [Google Scholar]
  26. MacDonald N. E., Halperin S. A., Law B. J., Danzig L. E., Granoff D. M. Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? JAMA. 2000 Apr 12;283(14):1826–1827. doi: 10.1001/jama.283.14.1826. [DOI] [PubMed] [Google Scholar]
  27. MacDonald N. E., Halperin S. A., Law B. J., Forrest B., Danzig L. E., Granoff D. M. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA. 1998 Nov 18;280(19):1685–1689. doi: 10.1001/jama.280.19.1685. [DOI] [PubMed] [Google Scholar]
  28. MacLennan J. M., Shackley F., Heath P. T., Deeks J. J., Flamank C., Herbert M., Griffiths H., Hatzmann E., Goilav C., Moxon E. R. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. JAMA. 2000 Jun 7;283(21):2795–2801. doi: 10.1001/jama.283.21.2795. [DOI] [PubMed] [Google Scholar]
  29. MacLennan J., Obaro S., Deeks J., Williams D., Pais L., Carlone G., Moxon R., Greenwood B. Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. Vaccine. 1999 Aug 6;17(23-24):3086–3093. doi: 10.1016/s0264-410x(99)00139-5. [DOI] [PubMed] [Google Scholar]
  30. Maiden M. C., Spratt B. G. Meningococcal conjugate vaccines: new opportunities and new challenges. Lancet. 1999 Aug 21;354(9179):615–616. doi: 10.1016/s0140-6736(99)00252-4. [DOI] [PubMed] [Google Scholar]
  31. Maslanka S. E., Gheesling L. L., Libutti D. E., Donaldson K. B., Harakeh H. S., Dykes J. K., Arhin F. F., Devi S. J., Frasch C. E., Huang J. C. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol. 1997 Mar;4(2):156–167. doi: 10.1128/cdli.4.2.156-167.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Maslanka S. E., Tappero J. W., Plikaytis B. D., Brumberg R. S., Dykes J. K., Gheesling L. L., Donaldson K. B., Schuchat A., Pullman J., Jones M. Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine. Infect Immun. 1998 Jun;66(6):2453–2459. doi: 10.1128/iai.66.6.2453-2459.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mateo S., Cano R., Garcia C. Changing epidemiology of meningococcal disease in Spain, 1989-1997. Euro Surveill. 1997 Oct;2(10):71–74. doi: 10.2807/esm.02.10.00146-en. [DOI] [PubMed] [Google Scholar]
  34. Raymond N. J., Reeves M., Ajello G., Baughman W., Gheesling L. L., Carlone G. M., Wenger J. D., Stephens D. S. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J Infect Dis. 1997 Nov;176(5):1277–1284. doi: 10.1086/514123. [DOI] [PubMed] [Google Scholar]
  35. Reingold A. L., Broome C. V., Hightower A. W., Ajello G. W., Bolan G. A., Adamsbaum C., Jones E. E., Phillips C., Tiendrebeogo H., Yada A. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet. 1985 Jul 20;2(8447):114–118. doi: 10.1016/s0140-6736(85)90224-7. [DOI] [PubMed] [Google Scholar]
  36. Richmond P., Borrow R., Miller E., Clark S., Sadler F., Fox A., Begg N., Morris R., Cartwright K. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis. 1999 Jun;179(6):1569–1572. doi: 10.1086/314753. [DOI] [PubMed] [Google Scholar]
  37. Richmond P., Goldblatt D., Fusco P. C., Fusco J. D., Heron I., Clark S., Borrow R., Michon F. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine. 1999 Nov 12;18(7-8):641–646. doi: 10.1016/s0264-410x(99)00276-5. [DOI] [PubMed] [Google Scholar]
  38. Richmond P., Kaczmarski E., Borrow R., Findlow J., Clark S., McCann R., Hill J., Barker M., Miller E. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis. 2000 Feb;181(2):761–764. doi: 10.1086/315284. [DOI] [PubMed] [Google Scholar]
  39. Robbins J. B., Myerowitz L., Whisnant J. K., Argaman M., Schneerson R., Handzel Z. T., Gotschlich E. C. Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3. Infect Immun. 1972 Nov;6(5):651–656. doi: 10.1128/iai.6.5.651-656.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Robbins J. B., Towne D. W., Gotschlich E. C., Schneerson R. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. Lancet. 1997 Sep 20;350(9081):880–882. doi: 10.1016/S0140-6736(97)03227-3. [DOI] [PubMed] [Google Scholar]
  41. Sacchi C. T., Zanella R. C., Caugant D. A., Frasch C. E., Hidalgo N. T., Milagres L. G., Pessoa L. L., Ramos S. R., Camargo M. C., Melles C. E. Emergence of a new clone of serogroup C Neisseria meningitidis in São Paulo, Brazil. J Clin Microbiol. 1992 May;30(5):1282–1286. doi: 10.1128/jcm.30.5.1282-1286.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Siber G. R. Pneumococcal disease: prospects for a new generation of vaccines. Science. 1994 Sep 2;265(5177):1385–1387. doi: 10.1126/science.8073278. [DOI] [PubMed] [Google Scholar]
  43. Swartley J. S., Marfin A. A., Edupuganti S., Liu L. J., Cieslak P., Perkins B., Wenger J. D., Stephens D. S. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):271–276. doi: 10.1073/pnas.94.1.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Twumasi P. A., Jr, Kumah S., Leach A., O'Dempsey T. J., Ceesay S. J., Todd J., Broome C. V., Carlone G. M., Pais L. B., Holder P. K. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis. 1995 Mar;171(3):632–638. doi: 10.1093/infdis/171.3.632. [DOI] [PubMed] [Google Scholar]
  45. Wang J. F., Caugant D. A., Morelli G., Koumaré B., Achtman M. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis. 1993 Jun;167(6):1320–1329. doi: 10.1093/infdis/167.6.1320. [DOI] [PubMed] [Google Scholar]
  46. Whalen C. M., Hockin J. C., Ryan A., Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA. 1995 Feb 1;273(5):390–394. [PubMed] [Google Scholar]
  47. Zhang Q., Choo S., Everard J., Jennings R., Finn A. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun. 2000 May;68(5):2692–2697. doi: 10.1128/iai.68.5.2692-2697.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES